Innovative Eyewear Secures Distribution Deal for Expansion Into Middle East Market

By Staff
Monday, September 9, 2024 12:18 AM MIAMI—Innovative Eyewear, Inc., a developer of ChatGPT-enabled smart eyewear, has announced an expansion into the Middle East market through an exclusive distribution agreement with Ecom Gulf FZCO (doing business as Mixireal).

It's Time to Cast Your Votes for Jobson's 2024 EyeVote Readers' Choice Awards—Nominations Close on Oct. 11

By Staff
Wednesday, September 4, 2024 12:24 AM NEW YORK—Vision Monday and 20/20 are hosting the 16th annual EyeVote Readers' Choice Awards to identify the optical industry’s favorite products and companies this year. These two Jobson Medical Information publications are teaming up once again this fall to get readers’ opinions by asking optical retailers and ECPs to identify their favorite products in 22 distinct categories.

SDC Technologies Aligns With James Robinson Speciality Ingredients for Photochromic Dyes

By Staff
Tuesday, September 3, 2024 12:21 AM IRVINE, Calif.—SDC Technologies, a developer and manufacturer of high-performance specialty coatings, has entered into a strategic alliance with James Robinson Speciality Ingredients that includes the purchase and exclusive licensing of their intellectual property and comprehensive patent portfolio of high-performance photochromic dyes.

Bruder Healthcare Introduces Eyeleve MGD Eye Drops

By Staff
Thursday, August 29, 2024 12:21 AM PLAINVILLE, Mass.—Bruder Healthcare, a Hilco Vision Company, announced that it has entered into an exclusive distribution agreement with Santen S.A. to market Eyeleve MGD, previously marketed in the United States as Retaine MGD.

Jobson Optical Group Announces Agenda and Speakers for 'The Artificial Intelligence Revolution' at Vision Expo West

By Staff
Thursday, August 22, 2024 12:18 AM LAS VEGAS—Jobson Optical Group has announced the speaker roster and agenda for “The Artificial Intelligence Revolution: Practical Applications in Eye Care Today,” a new, live event, which will be presented at The Venetian Hotel during Vision Expo West 2024. The program is scheduled for Wednesday, September 18, from 3:00 to 5:30 pm. Dr. Scot Morris, OD, director of development and CEO of Augmented Medical Intelligence, a medical knowledge platform transforming medicine, will chair the presentation.

Eyefinity Earns Three Best-in-Class Security Accreditations

By Staff
Tuesday, August 13, 2024 12:21 AM RANCHO CORDOVA, Calif.—Eyefinity, a VSP Vision company and a provider of cloud-based practice management and electronic health records (EHR) software, has earned three top-of-the-line security accreditations, the company has announced.

VSP Future of Senses Report Redefines Sight, Sound, Smell, Taste and Touch

By Staff
Monday, August 12, 2024 12:21 AM RANCHO CORDOVA, Calif.—VSP has released “The Future of Senses,” a new report from the VSP Vision Global Innovation Center that showcases the wave of sensory startups and innovations transforming how we experience the world.

LensCrafters Launches Premium, Proprietary Vision Solution With Adaptive Progressive Lenses

By Staff
Monday, July 29, 2024 12:15 AM NEW YORK—LensCrafters, part of EssilorLuxottica Group, announced it is launching LensCrafters Adaptive Progressive Lenses. The company partnered with Essilor Instruments and Shamir Optical Industry Ltd., a world-leading producer of high-performance lenses, to develop the new vision solution, exclusively available at LensCrafters stores in North America. LensCrafters said it leveraged “the best of EssilorLuxottica Group to build the new top tier lens, including investing in new technology to gather additional parameters necessary for lens customization. Utilizing AI big data technology in partnership with Shamir, ten years of prescription data were analyzed for identifying consumer needs and defining the technical specifications for the design of the lenses. Lastly, LensCrafters partnered with the operations and manufacturing teams to set up all the required industrial mechanisms to produce and distribute the lenses on a big scale ensuring a high level of service to customers."

EssilorLuxottica Days 2024 Draws to a Close, Provides Glimpse Into Design, Manufacturing and Craftsmanship

By Staff
Thursday, July 25, 2024 12:24 AM CHARENTON-LE-PONT, France; VENICE and MILAN—EssilorLuxottica has wrapped up its 2024 EssilorLuxottica Days experience, giving eyecare practitioners and customers from the U.S. and throughout the world the ability to experience a behind-the-scenes look at the company's eyewear design and manufacturing from start to finish.

Ultimate Partners: A Special 20/20 and Vision Monday Section Celebrates Readers' Nominations of Outstanding 2024 Business Support Partners

By Staff
Tuesday, July 16, 2024 12:18 AM NEW YORK—Now in its fourth year, Jobson’s 2024 Ultimate Partners program gives readers the opportunity to highlight their great business support partners and showcase their support.

How the Optical Industry Views Artificial Intelligence

By Staff
Friday, June 28, 2024 12:15 AM NEWARK, N.J.—Despite a somewhat cautionary approach, the use of artificial intelligence (AI) appears to be gaining traction both among eyecare professionals and optical companies. In the June issue of Vision Monday, we take a look at the impact AI is making in the everyday professional lives of ECPs and among optical retailers. A growing number of optical businesses, including frame and lens manufacturers, wholesalers and retailers, are employing AI for a variety of tasks.

Alcon’s Unity VCS and Unity CS Receive FDA 510(k) Clearance

By Staff
Tuesday, June 25, 2024 12:18 AM GENEVA—Alcon, a global eyecare company with a portfolio of surgical and vision care products, has announced that it has received FDA 510(k) clearance for the Unity Vitreoretinal Cataract System and Unity Cataract System, the first products to be introduced from Alcon’s Unity portfolio.

Neurotech Pharmaceuticals Receives Priority Review of Biologics License Application From the FDA for Treatment of Retinal Disease

By Staff
Friday, June 21, 2024 12:18 AM CUMBERLAND, R.I.—The U.S. Food and Drug Administration has determined that the Biologic License Application conducted by Neurotech Pharmaceuticals Inc., for NT-501, an investigational encapsulated cell therapy for the treatment of MacTel, is sufficiently complete to permit a substantive review, according to an announcement from Neurotech.

Optical Gains Traction in Adopting Artificial Intelligence

By Staff
Sunday, June 16, 2024 2:00 AM As artificial intelligence (AI) continues to penetrate nearly every industry and aspect of our everyday lives, ECPs and optical retailers are taking a hard look at the technology, and appear to be in various stages of implementing it into their business models and strategies. It also appears that AI is ready to permeate the optical industry as well, with the promise of more efficient processes that can benefit both providers and patients/consumers.

Cutting Edge AI Technology Helps The Eye Place Diagnose Eye Conditions

By Staff
Sunday, June 16, 2024 1:59 AM As artificial intelligence (AI) continues to penetrate nearly every industry and aspect of our everyday lives, ECPs and optical retailers are taking a hard look at the technology, and appear to be in various stages of implementing it into their business models and strategies. It also appears that AI is ready to permeate the optical industry as well, with the promise of more efficient processes that can benefit both providers and patients/consumers.